Discovery Pharmaceuticals Ltd

The Old Vicarage, Market Place, Castle Donington, Derbyshire, DE74 2JB
Telephone: +44 (0) 845 2416616
Fax: +44 (0) 845 2419919
Medical Information Direct Line: 0
Medical Information e-mail: medinfo@discoverypharma.co.uk

Summary of Product Characteristics last updated on the eMC: 19/02/2010
SPC Amlostin 10mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 6. 3 - Shelf Life
  • Change to section 7 - Marketing Authorisation Holder
  • Change to MA holder contact details
Date of revision of text on the SPC:   11-Jun-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



·          Change in name of product in the UK - Amlodipine to Amlostin 09/06/04

·          Change in name of MAH in the UK (SPUK to Genus Pharmaceuticals Ltd) 12/04/05

·          Shelf life extension - 24 mths to 36 mths  26/06/06

·          Change to address for UK MAH Genus Pharmaceuticals 13/06/2008

 

 

 

 

 

Updated on 22/09/2004 and displayed until 19/02/2010
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   amlodipine maleate